Table 4.
Authors | N 1 | N 2 | Carnitine Dosage | Mean 1 | SD 1 | Mean 2 | SD 2 | SMD | SE | 95% CI | t | p | Weight (%) | Test for Heterogeneity | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fixed | Random | |||||||||||||||
Colombani 1996 | 7 | 7 | 4 g/d. 1 d | 1.3 | 0.1 | 1.4 | 0.1 | −0.936 | 0.531 | −2.092 to 0.220 | 7.93 | 7.93 | Q | 8.0319 | ||
Chun 2011 | 6 | 6 | 2 g/d. 4 w | 1.88 | 0.46 | 1.78 | 0.28 | 0.242 | 0.535 | −0.950 to 1.434 | 7.80 | 7.80 | DF | 10 | ||
Chun 2011 | 6 | 6 | 3 g/d. 4 w | 1.41 | 0.80 | 1.04 | 0.49 | 0.515 | 0.543 | −0.695 to 1.725 | 7.57 | 7.57 | Significance level | p = 0.6257 | ||
Chun 2011 | 6 | 6 | 4 g/d. 4 w | 1.10 | 0.23 | 1.29 | 0.36 | −0.580 | 0.546 | −1.796 to 0.636 | 7.49 | 7.49 | I2 (inconsistency) | 0.00% | ||
Chun 2011 | 6 | 6 | 5 g/d. 4 w | 1.38 | 0.57 | 1.50 | 0.79 | −0.161 | 0.534 | −1.350 to 1.029 | 7.83 | 7.83 | 95% CI for I2 | 0.00 to 50.67 | ||
Chun 2011 | 6 | 6 | 6 g/d. 4 w | 1.38 | 0.47 | 1.31 | 0.25 | 0.172 | 0.534 | −1.018 to 1.361 | 7.83 | 7.83 | ||||
Greig 1987 | 9 | 9 | 2 g/d. 2 w | 1.04 | 0.66 | 1.14 | 0.28 | −0.188 | 0.450 | −1.142 to 0.766 | 11.02 | 11.02 | ||||
Greig 1987 | 10 | 10 | 2 g/d. 4 w | 0.8 | 0.3 | 0.9 | 0.3 | −0.319 | 0.431 | −1.225 to 0.587 | 12.00 | 12.00 | ||||
Oyono-Enguelle 1988 | 10 | 10 | 2 g/d. 4 w | 0.93 | 0.35 | 0.86 | 0.34 | 0.194 | 0.429 | −0.708 to 1.096 | 12.11 | 12.11 | ||||
Watcher 2002 | 8 | 8 | 4 g/d. 12 w | 0.9 | 0.1 | 0.8 | 0.2 | 0.598 | 0.484 | −0.441 to 1.637 | 9.52 | 9.52 | ||||
Wyss 1990 | 7 | 7 | 3 g/d. 1 w | 1.5 | 0.7 | 1.4 | 0.7 | 0.134 | 0.501 | −0.958 to 1.225 | 8.90 | 8.90 | ||||
Total (fixed effects) | 81 | 81 | −0.0257 | 0.149 | −0.321 to 0.269 | −0.172 | 0.864 | 100.00 | 100.00 | |||||||
Total (random effects) | 81 | 81 | −0.0257 | 0.149 | −0.321 to 0.269 | −0.172 | 0.864 | 100.00 | 100.00 | |||||||
Chun 2011 | 6 | 6 | 2 g/d. 4 w | 1.88 | 0.46 | 1.78 | 0.28 | 0.242 | 0.535 | −0.950 to 1.434 | 24.44 | 24.44 | Q | 0.9555 | ||
Greig 1987 | 10 | 10 | 2 g/d. 4 w | 0.8 | 0.3 | 0.9 | 0.3 | −0.319 | 0.431 | −1.225 to 0.587 | 37.62 | 37.62 | DF | 2 | ||
Oyono-Enguelle 1988 | 10 | 10 | 2 g/d. 4 w | 0.93 | 0.35 | 0.86 | 0.34 | 0.194 | 0.429 | −0.708 to 1.096 | 37.94 | 37.94 | Significance level | p = 0.6202 | ||
Total (fixed effects) | 26 | 26 | 0.0129 | 0.264 | −0.518 to 0.544 | 0.0486 | 0.961 | 100.00 | 100.00 | I2 | 0.00% | |||||
Total (random effects) | 26 | 26 | 0.0129 | 0.264 | −0.518 to 0.544 | 0.0486 | 0.961 | 100.00 | 100.00 | 95% CI for I2 | 0.00 to 92.98 |
Mm: Millimoles, l: liter, d: day; L-carn: L-carnitine, N: number of subjects, 1: subjects that did not use supplementation, 2: subjects used L-carnitine, g: grams, w: weeks, SMD: standard mean differences, SE: standard error, CI: confidential intervals, SD: standard deviation, I2: inconsistency.